All News

Filter News

Filter by

News Type
Topic
Language
Published Date

Filter by News Type

Done

Filter by Topic

Done

Filter by Language

Done

Filter by Published Date

Done
Showing 10 out of 72 results
A researcher analyzes a blood sample in a laboratory.
|
News Release
A new study by researchers at the National Institutes of Health and their colleagues has found that SARS-CoV-2, the virus that causes COVID-19, does not appear to pose a threat to the safety of the nation’s blood supply. The analysis, published in Transfusion , supports current donor screening guidelines, including those used by the U.S. Food and...
CEAL collage image
|
News Release
Los Institutos Nacionales de la Salud (NIH, por sus siglas en inglés) han autorizado $29 millones de dólares en subvenciones adicionales para la Coalición “Alianza de Participación Comunitaria (CEAL, por sus siglas en inglés) de NIH contra las disparidades del COVID-19”. Esta financiación , parte del Plan de Rescate Estadounidense, esta dirigida a...
CEAL collage image
|
News Release
To bolster research to help communities disproportionately affected by COVID-19, the National Institutes of Health is funding $29 million in additional grants for the NIH Community Engagement Alliance (CEAL) Against COVID-19 Disparities. This funding was supported by the American Rescue Plan. The awards will provide $15 million to 11 teams already...
Attending physicians take care of an older man in a hospital who is recovering from COVID-19.
|
NHLBI in the Press
After studying 1,022 patients hospitalized for COVID-19, researchers created three categories – adverse, moderate, and favorable – that described their clinical outcomes. More research is necessary to evaluate how these models may inform medical practice.
An image shows SARS-CoV-2 (green) infecting heart cells (red).
Credit: Lina Greenberg
|
NHLBI in the Press
To formulate evidence-based guidelines and develop personalized therapies for COVID-19, researchers study how the virus infects different organs and systems – including the heart. A new study identifies underlying pathways and cell changes related to cardiovascular complications from COVID-19.
Microscopic image of the novel coronavirus
|
Statement
The National Institutes of Health (NIH) has launched the last of three Phase 3 clinical trials to evaluate the safety and effectiveness of blood thinners to prevent life-threatening blood clots in adults diagnosed with COVID-19. The first patient in the trial was enrolled on February 15. Part of the   Accelerating COVID-19 Therapeutic Interventions...